Related Experiment Video
Updated: Aug 20, 2026

Oral Biofilm Sampling for Microbiome Analysis in Healthy Children
Published on: December 31, 2017
Exploring the Early-Life Microbiomes of Preterm Infants and Their Childhood Health Outcomes (The BLOOM Study):
Michelle R Asbury1,2,3,4, Andrea Guedez1,2,3,4, Jessica Lee1,2,3,4
1Department of Physiology & Pharmacology, University of Calgary, 3330 Hospital Dr NW, HRIC Room 4A25, Calgary, AB, T2N 1N4, Canada, 1 403-220-7803, 1 403-220-7803.
Insights
The BLOOM study tracks preterm infants' gut microbiome development for three years, linking it to long-term health outcomes like asthma and neurodevelopment. This research aims to identify risk factors and inform interventions for improved infant health.
Area of Science:
- Microbiome research
- Pediatric health
- Developmental biology
Background:
- Early-life gut microbiome establishment is crucial for long-term health.
- Preterm infants have disrupted microbial colonization, increasing risks for conditions like asthma and impaired neurodevelopment.
- Understanding preterm infant microbiome development is key to optimizing health and developing interventions.
Purpose of the Study:
- To examine how early-life microbiomes influence the health and development of preterm infants into childhood.
- To investigate the factors predicting microbial patterns in preterm infants.
- To establish links between the preterm infant microbiome and childhood health outcomes.
Main Methods:
- Prospective, observational cohort study (BLOOM) recruiting infants (<37 weeks gestation) and families.
- Collection of maternal and infant biological samples (stool, urine, human milk, nasal swabs, hair, blood) over three years.
- Assessment of health outcomes and developmental milestones through clinical testing and questionnaires.
Main Results:
- Recruitment for BLOOM commenced in 2019, with 245 participants enrolled as of May 2026.
- Ongoing recruitment and data collection for this comprehensive cohort study and biobank.
- Initial characterization of early-life microbiome profiles for the first 105 infants published in December 2025.
Conclusions:
- The BLOOM study provides a comprehensive resource for understanding preterm infant microbiome development.
- Characterizing microbiome patterns and correlating them with health outcomes will identify disease risk factors.
- Results will inform the design of microbial therapeutics and generate hypotheses on microbiome-health links.
Background:
Establishment of the gut microbiome during the first years of life is critically important for long-term health and development. In preterm infants, microbial colonization is disrupted due to their developmental immaturity and the myriad of pre- and postnatal exposures. Unfortunately, this places them at an elevated risk for adverse health outcomes into childhood (eg, asthma and impaired neurodevelopment). Understanding the developmental trajectory of the microbiome in preterm infants, the factors predicting these microbial patterns, and the links to childhood health can offer opportunities to develop interventions and optimize health.
Objective:
BLOOM (Begin a Life of Health With Observation and Optimization of the Microbiome) is a prospective, observational cohort study that aims to examine how early-life microbiomes shape the health and development of preterm infants into childhood (eg, asthma and neurodevelopment).
Methods:
Infants (<37 weeks gestation) and their families are recruited from 4 neonatal intensive care units in Calgary, Alberta, Canada. Maternal stool and weekly infant stool, urine, and human milk samples are collected during the first 2 months postnatally; participants are then followed up at 3 months, 1 year, and 3 years corrected age for continued data (eg, nutrition, medications, medical history, and home environment) and sample collection (stool, urine, nasal swabs, hair, and blood). Additional clinical testing (eg, allergen skin prick test) and questionnaires (eg, Ages & Stages Questionnaires, Third Edition) are administered to assess health outcomes and developmental milestones.
Results:
Study recruitment and data/sample collection for BLOOM commenced in 2019; as of May 2026, we have enrolled 245 participants, and recruitment is ongoing. An initial characterization of early-life microbiome profiles for the first 105 infants enrolled in BLOOM was published online in December 2025.
Conclusions:
BLOOM is a large, comprehensive prospective cohort study and biobank aimed at measuring the microbiome development of preterm-born children. This cohort will address significant research priorities through characterizing the patterns of microbiome development in preterm infants over the first 3 years postnatally and correlating these with health outcomes (eg, immune development, asthma and allergy risks, and neurodevelopment). It is anticipated that the results can be leveraged to identify factors and altered microbiome patterns underlying disease risk, design intervention strategies (eg, microbial therapeutics) for later clinical testing, and generate novel hypotheses of possible underlying mechanisms linking microbiome development to health.
Related Concept Videos
Development of the Oral Microbiota
Development of Human Microbiota
Microbiota Modulation by Antibiotics
Anatomy of the Intestines
Small Intestines
The small intestine is an ~7 meter-long tube with an inner diameter of just 2.5 cm. Since most nutrients are absorbed here, the inner lining of the small...
Introduction to the Human Microbiota
